Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

GLMD

GLMD News

Newswire

08:33

Galmed Pharmaceuticals receives new patent for Aramchol treatment.

08:37

Galmed Pharmaceuticals: Letter to Shareholders Highlights Therapeutic Focus, Ambitious Plans

08:37

Galmed Pharmaceuticals: CEO Letter to Shareholders Highlights Strong Cash Position, Scientific Advancements, and Growth Opportunities

09:46

Galmed Pharmaceuticals Reports Q3 Loss of $1.9mln, Highlights Pipeline Progress

08:34

Galmed Pharmaceuticals reports $2mln net loss in Q3 2025, cash at $19.2mln.

View More

About GLMD

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More